Literature DB >> 16422805

The Sexual Interest and Desire Inventory-Female (SIDI-F): item response analyses of data from women diagnosed with hypoactive sexual desire disorder.

Terrence Sills1, Glen Wunderlich, Robert Pyke, R Taylor Segraves, Sandra Leiblum, Anita Clayton, Dan Cotton, Kenneth Evans.   

Abstract

INTRODUCTION: Hypoactive sexual desire disorder (HSDD) is the most common sexual complaint in women. Currently there are no validated instruments for specifically assessing HSDD severity, or change in HSDD severity in response to treatment, in premenopausal women. The Sexual Interest and Desire Inventory-Female (SIDI-F) is a clinician-administered instrument that was developed to measure severity and change in response to treatment of HSDD. Seventeen items were included in a preliminary version of the SIDI-F, including 10 items related to desire, and seven items related to possible comorbid factors (e.g., other kinds of sexual dysfunction, general relationship satisfaction, mood, and fatigue). AIM: The aim of the study was to use the outcome of item response analyses of blinded data from two randomized, placebo-controlled trials, to assist in the revision of the scale.
METHODS: A nonparametric item response (IRT) model was used to assess the relation between item functioning and HSDD severity on this preliminary version of the SIDI-F.
RESULTS: Results show that the majority of SIDI-F items demonstrated good sensitivity to differences in overall HSDD severity. That is, there was an orderly relation between differences in option selection for an item and differences in overall HSDD severity. The IRT analyses further indicated that revisions were warranted for a number of these items. Five items were not sensitive to differences in HSDD severity and were removed from the scale.
CONCLUSION: The SIDI-F is a brief, clinician-administered rating scale designed to assess severity of HSDD symptoms in women. IRT analyses show that majority of the items of the SIDI-F function well in discriminating individual differences in HSDD severity. A revised 13-item version of the SIDI-F is currently undergoing further validation.

Entities:  

Mesh:

Year:  2005        PMID: 16422805     DOI: 10.1111/j.1743-6109.2005.00146.x

Source DB:  PubMed          Journal:  J Sex Med        ISSN: 1743-6095            Impact factor:   3.802


  5 in total

1.  Cues resulting in desire for sexual activity in women.

Authors:  Katie McCall; Cindy Meston
Journal:  J Sex Med       Date:  2006-09       Impact factor: 3.802

2.  An item response analysis of the motor and behavioral subscales of the unified Huntington's disease rating scale in huntington disease gene expansion carriers.

Authors:  Anthony L Vaccarino; Karen Anderson; Beth Borowsky; Kevin Duff; Joseph Giuliano; Mark Guttman; Aileen K Ho; Michael Orth; Jane S Paulsen; Terrence Sills; Daniel P van Kammen; Kenneth R Evans
Journal:  Mov Disord       Date:  2011-03-02       Impact factor: 10.338

Review 3.  The Depression Inventory Development Workgroup: A Collaborative, Empirically Driven Initiative to Develop a New Assessment Tool for Major Depressive Disorder.

Authors:  Anthony L Vaccarino; Kenneth R Evans; Amir H Kalali; Sidney H Kennedy; Nina Engelhardt; Benicio N Frey; John H Greist; Kenneth A Kobak; Raymond W Lam; Glenda MacQueen; Roumen Milev; Franca M Placenza; Arun V Ravindran; David V Sheehan; Terrence Sills; Janet B W Williams
Journal:  Innov Clin Neurosci       Date:  2016-10-01

Review 4.  What Sexual Behaviors Relate to Decreased Sexual Desire in Women? A Review and Proposal for End Points in Treatment Trials for Hypoactive Sexual Desire Disorder.

Authors:  Robert Pyke; Anita Clayton
Journal:  Sex Med       Date:  2016-12-29       Impact factor: 2.491

5.  Systematic review of the psychometric properties of instruments to measure sexual desire.

Authors:  Denisse Cartagena-Ramos; Miguel Fuentealba-Torres; Flávio Rebustini; Ana Carolina Andrade Biaggi Leite; Willyane de Andrade Alvarenga; Ricardo Alexandre Arcêncio; Rosana Aparecida Spadoti Dantas; Lucila Castanheira Nascimento
Journal:  BMC Med Res Methodol       Date:  2018-10-19       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.